title: Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantrone.
authors.forename: C
authors.initials: C
authors.lastname: Heesen
authors.forename: M
authors.initials: M
authors.lastname: Bruegmann
authors.forename: J
authors.initials: J
authors.lastname: Gbdamosi
authors.forename: E
authors.initials: E
authors.lastname: Koch
authors.forename: A
authors.initials: A
authors.lastname: Mönch
authors.forename: C
authors.initials: C
authors.lastname: Buhmann
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced*; D008942:Mitoxantrone / Q000009:adverse effects*; D009103:Multiple Sclerosis / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D008942:Mitoxantrone